关注
Jeremy Shapiro
Jeremy Shapiro
在 monash.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
CS Karapetis, S Khambata-Ford, DJ Jonker, CJ O'Callaghan, D Tu, ...
New England Journal of Medicine 359 (17), 1757-1765, 2008
44942008
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, ...
Journal of Clinical Oncology 38 (32), 3763-3772, 2020
5752020
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang, S Kosmider, R Wong, ...
New England Journal of Medicine 386 (24), 2261-2272, 2022
4682022
Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 …
W Abida, D Campbell, A Patnaik, JD Shapiro, B Sautois, NJ Vogelzang, ...
Clinical Cancer Research 26 (11), 2487-2496, 2020
3482020
Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel
JD Shapiro, MJ Millward, D Rischin, M Michael, V Walcher, PA Francis, ...
Gynecologic oncology 63 (1), 89-93, 1996
2951996
PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17
CS Karapetis, D Jonker, M Daneshmand, JE Hanson, CJ O'Callaghan, ...
Clinical Cancer Research 20 (3), 744-753, 2014
1902014
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial
DJ Jonker, L Nott, T Yoshino, S Gill, J Shapiro, A Ohtsu, J Zalcberg, ...
The lancet Gastroenterology & hepatology 3 (4), 263-270, 2018
1492018
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously …
L Lim, P Gibbs, D Yip, JD Shapiro, R Dowling, D Smith, A Little, W Bailey, ...
BMC cancer 5, 1-6, 2005
1482005
Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall and KRAS-Specific Results of the NCIC CTG and …
HJ Au, CS Karapetis, CJ O'Callaghan, D Tu, MJ Moore, JR Zalcberg, ...
Journal of Clinical Oncology 27 (11), 1822-1828, 2009
1282009
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild …
LL Siu, JD Shapiro, DJ Jonker, CS Karapetis, JR Zalcberg, J Simes, ...
J Clin Oncol 31 (19), 2477-2484, 2013
1262013
Management of advanced gastric cancer
TJ Price, JD Shapiro, E Segelov, CS Karapetis, N Pavlakis, E Van Cutsem, ...
Expert review of gastroenterology & hepatology 6 (2), 199-209, 2012
1042012
The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic …
T Prasanna, CS Karapetis, D Roder, J Tie, R Padbury, T Price, R Wong, ...
Acta Oncologica 57 (11), 1438-1444, 2018
1022018
Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous …
W Abida, AH Bryce, NJ Vogelzang, RJ Amato, JD Shapiro, R McDermott, ...
Annals of Oncology 29, viii272, 2018
942018
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
DJ Jonker, CS Karapetis, C Harbison, CJ O'Callaghan, D Tu, RJ Simes, ...
British journal of cancer 110 (3), 648-655, 2014
942014
A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma
M Peeters, AH Strickland, M Lichinitser, AVS Suresh, G Manikhas, ...
British journal of cancer 108 (3), 503-511, 2013
902013
Acute renal failure in critical illness conventional dialysis versus acute continuous hemodiafiltration
R BELLOMO, D MANSFIELD, S RUMBLE, J SHAPIRO, G PARKIN, ...
ASAIO journal 38 (3), M654-M657, 1992
861992
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies
L Lim, P Gibbs, D Yip, JD Shapiro, R Dowling, D Smith, A Little, W Bailey, ...
Internal medicine journal 35 (4), 222-227, 2005
852005
Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC …
W Abida, D Campbell, A Patnaik, B Sautois, J Shapiro, NJ Vogelzang, ...
Annals of Oncology 30, v327-v328, 2019
832019
A randomized controlled trial of a nurse-led supportive care package (SurvivorCare) for survivors of colorectal cancer
M Jefford, K Gough, A Drosdowsky, L Russell, S Aranda, P Butow, ...
The oncologist 21 (8), 1014-1023, 2016
782016
Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal
L Lim, M Chao, J Shapiro, JL Millar, D Kipp, A Rezo, A Fong, IT Jones, ...
Diseases of the colon & rectum 50 (12), 2032-2039, 2007
752007
系统目前无法执行此操作,请稍后再试。
文章 1–20